Armata Pharmaceuticals, Inc. (ARMP) financial statements (2021 and earlier)

Company profile

Business Address 4503 GLENCOE AVENUE
MARINA DEL REY, CA 90292
State of Incorp. WA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10685697
Cash and cash equivalents10685697
Receivables    000
Other undisclosed current assets1100110
Total current assets:117856107
Noncurrent Assets
Operating lease, right-of-use asset112
Property, plant and equipment2211111
Intangible assets, net (including goodwill)141435102020
Goodwill33   88
Intangible assets, net (excluding goodwill)101035101212
Restricted cash and investments11     
Other noncurrent assets10     
Other undisclosed noncurrent assets  00000
Total noncurrent assets:291936122122
TOTAL ASSETS:40251211183129
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2132211
Accounts payable1111   
Employee-related liabilities  11100
Interest and dividends payable  000  
Other undisclosed accounts payable and accrued liabilities1100111
Debt 1  1  
Deferred compensation liability11     
Due to related parties     0 
Business combination, contingent consideration, liability21     
Deferred revenue and credits  00
Other liabilities    0  
Other undisclosed current liabilities2   110
Total current liabilities:7532422
Noncurrent Liabilities
Long-term debt and lease obligation112     
Operating lease, liability112
Liabilities, other than long-term debt3411533
Deferred tax liabilities, net11233
Deferred income tax liabilities33
Business combination, contingent consideration, liability 1     
Derivative instruments and hedges, liabilities  002  
Other undisclosed noncurrent liabilities     118
Total noncurrent liabilities:146115521
Total liabilities:2111338723
Temporary equity, carrying amount     12 
Stockholders' equity
Stockholders' equity attributable to parent, including:19158810133
Common stock0000002
Additional paid in capital198172414402391375363
Accumulated deficit(180)(158)(406)(394)(381)(363)(362)
Warrants and rights outstanding      6
Other undisclosed stockholders' equity attributable to parent      (6)
Other undisclosed stockholders' equity      2
Total stockholders' equity:19158810135
TOTAL LIABILITIES AND EQUITY:40251211183129

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:   0000
Operating expenses(22)(20)(13)(16)(24)(11)(15)
Other operating income, net
(Other Expenses)
      37
Other undisclosed operating income (loss)1     (37)
Operating loss:(22)(20)(13)(16)(23)(10)(14)
Nonoperating income (expense)(1)00241028
Debt instrument, convertible, beneficial conversion feature      28
Other nonoperating income (expense)(1)002410 
Interest and debt expense(1)(1)  (0)  
Other undisclosed income from continuing operations before equity method investments, income taxes11  0  
Income (loss) from continuing operations before income taxes:(22)(19)(12)(14)(19)(1)14
Income tax benefit  0110 
Net income (loss):(22)(19)(12)(13)(19)(1)14
Other undisclosed net income attributable to parent      9
Net income (loss) attributable to parent:(22)(19)(12)(13)(19)(1)23
Preferred stock dividends and other adjustments    (2)(10)(1)
Other undisclosed net loss available to common stockholders, basic    (4)  
Net income (loss) available to common stockholders, basic:(22)(19)(12)(13)(24)(11)22
Other undisclosed net loss available to common stockholders, diluted (1)(0)(2)   
Net income (loss) available to common stockholders, diluted:(22)(20)(12)(14)(24)(11)22

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(22)(19)(12)(13)(19)(1)14
Comprehensive income (loss), net of tax, attributable to parent:(22)(19)(12)(13)(19)(1)14

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: